World

Top 946 largest Companies in the Biotechnology industry in the World by Market Cap

This is the list of the largest public listed companies in the Biotechnology industry in the world by market capitalization with links to their reference stock.

World Biotechnology Industry Analysis
World Top Companies World Companies Analysis

Top Biotechnology Companies in the World as of Jul. 01, 2025

Rank Company Market Cap (USD) Country Sector Industry
481 AnGes, Inc. $139.1 M Japan Japanese Healthcare Japanese Biotechnology
482 Scancell Holdings plc $139.0 M United Kingdom UK Healthcare UK Biotechnology
483 Assembly Biosciences, Inc. $138.5 M United States US Healthcare US Biotechnology
484 Galectin Therapeutics, Inc. $138.0 M United States US Healthcare US Biotechnology
485 Talaris Therapeutics, Inc. $137.4 M

(July 1, 2023)

 United States US Healthcare US Biotechnology
486 OSE Immunotherapeutics SA $137.3 M France French Healthcare French Biotechnology
487 Strongbridge Biopharma plc $135.7 M

(Oct. 1, 2021)

 United States US Healthcare US Biotechnology
488 CanBas Co. Ltd $135.5 M Japan Japanese Healthcare Japanese Biotechnology
489 Diaceutics plc $135.4 M United Kingdom UK Healthcare UK Biotechnology
490 Selecta Biosciences, Inc. $135.2 M

(Jan. 1, 2024)

 United States US Healthcare US Biotechnology
491 Greenwich LifeSciences, Inc. $134.1 M United States US Healthcare US Biotechnology
492 Seer, Inc. $133.6 M United States US Healthcare US Biotechnology
493 RAPT Therapeutics, Inc. $133.1 M United States US Healthcare US Biotechnology
494 StemRIM $132.6 M Japan Japanese Healthcare Japanese Biotechnology
495 SYN-TECH Chem. & Pharm. Co. Ltd $131.7 M Taiwan Taiwanese Healthcare Taiwanese Biotechnology
496 BriaCell Therapeutics Corp $131.7 M

(Dec. 1, 2021)

 Canada Canadian Healthcare Canadian Biotechnology
497 G1 Therapeutics, Inc. $131.2 M

(July 1, 2024)

 United States US Healthcare US Biotechnology
498 aTyr Pharma, Inc. $131.1 M United States US Healthcare US Biotechnology
499 Sangamo Therapeutics, Inc. $129.3 M United States US Healthcare US Biotechnology
500 Transgene SA $128.5 M France French Healthcare French Biotechnology
501 BioGend Therapeutics Co. Ltd $128.5 M Taiwan Taiwanese Healthcare Taiwanese Biotechnology
502 Fate Therapeutics, Inc. $128.4 M United States US Healthcare US Biotechnology
503 Sesen Bio, Inc. $128.0 M

(March 1, 2023)

 United States US Healthcare US Biotechnology
504 Faron Pharmaceuticals OY $127.9 M

(July 1, 2024)

 Finland Finnish Healthcare Finnish Biotechnology
505 Sensorion SA $126.3 M France French Healthcare French Biotechnology
506 Diamyd Medical AB $126.1 M

(July 1, 2024)

 Sweden Swedish Healthcare Swedish Biotechnology
507 Paratek Pharmaceuticals, Inc. $125.7 M

(July 1, 2023)

 United States US Healthcare US Biotechnology
508 Infant Bacterial Therapeutics AB $124.4 M

(July 1, 2024)

 Sweden Swedish Healthcare Swedish Biotechnology
509 Nkarta, Inc. $124.2 M United States US Healthcare US Biotechnology
510 ReproCELL, Inc. $124.1 M Japan Japanese Healthcare Japanese Biotechnology

Top Biotechnology Companies in the World as of Jul. 01, 2025

481. AnGes, Inc.

Company Profile: AnGes, Inc.
Market Cap (USD): $139.1 M
Country: Japan
Sector: Japanese Healthcare
Industry: Japanese Biotechnology

482. Scancell Holdings plc

Company Profile: Scancell Holdings plc
Market Cap (USD): $139.0 M
Country: United Kingdom
Sector: UK Healthcare
Industry: UK Biotechnology

483. Assembly Biosciences, Inc.

Company Profile: Assembly Biosciences, Inc.
Market Cap (USD): $138.5 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

484. Galectin Therapeutics, Inc.

Company Profile: Galectin Therapeutics, Inc.
Market Cap (USD): $138.0 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

485. Talaris Therapeutics, Inc.

Company Profile: Talaris Therapeutics, Inc.
Market Cap (USD): $137.4 M (July 1, 2023)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

486. OSE Immunotherapeutics SA

Company Profile: OSE Immunotherapeutics SA
Market Cap (USD): $137.3 M
Country: France
Sector: French Healthcare
Industry: French Biotechnology

487. Strongbridge Biopharma plc

Company Profile: Strongbridge Biopharma plc
Market Cap (USD): $135.7 M (Oct. 1, 2021)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

488. CanBas Co. Ltd

Company Profile: CanBas Co. Ltd
Market Cap (USD): $135.5 M
Country: Japan
Sector: Japanese Healthcare
Industry: Japanese Biotechnology

489. Diaceutics plc

Company Profile: Diaceutics plc
Market Cap (USD): $135.4 M
Country: United Kingdom
Sector: UK Healthcare
Industry: UK Biotechnology

490. Selecta Biosciences, Inc.

Company Profile: Selecta Biosciences, Inc.
Market Cap (USD): $135.2 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

491. Greenwich LifeSciences, Inc.

Company Profile: Greenwich LifeSciences, Inc.
Market Cap (USD): $134.1 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

492. Seer, Inc.

Company Profile: Seer, Inc.
Market Cap (USD): $133.6 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

493. RAPT Therapeutics, Inc.

Company Profile: RAPT Therapeutics, Inc.
Market Cap (USD): $133.1 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

494. StemRIM

Company Profile: StemRIM
Market Cap (USD): $132.6 M
Country: Japan
Sector: Japanese Healthcare
Industry: Japanese Biotechnology

495. SYN-TECH Chem. & Pharm. Co. Ltd

Company Profile: SYN-TECH Chem. & Pharm. Co. Ltd
Market Cap (USD): $131.7 M
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Biotechnology

496. BriaCell Therapeutics Corp

Company Profile: BriaCell Therapeutics Corp
Market Cap (USD): $131.7 M (Dec. 1, 2021)
Country: Canada
Sector: Canadian Healthcare
Industry: Canadian Biotechnology

497. G1 Therapeutics, Inc.

Company Profile: G1 Therapeutics, Inc.
Market Cap (USD): $131.2 M (July 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

498. aTyr Pharma, Inc.

Company Profile: aTyr Pharma, Inc.
Market Cap (USD): $131.1 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

499. Sangamo Therapeutics, Inc.

Company Profile: Sangamo Therapeutics, Inc.
Market Cap (USD): $129.3 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

500. Transgene SA

Company Profile: Transgene SA
Market Cap (USD): $128.5 M
Country: France
Sector: French Healthcare
Industry: French Biotechnology

501. BioGend Therapeutics Co. Ltd

Company Profile: BioGend Therapeutics Co. Ltd
Market Cap (USD): $128.5 M
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Biotechnology

502. Fate Therapeutics, Inc.

Company Profile: Fate Therapeutics, Inc.
Market Cap (USD): $128.4 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

503. Sesen Bio, Inc.

Company Profile: Sesen Bio, Inc.
Market Cap (USD): $128.0 M (March 1, 2023)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

504. Faron Pharmaceuticals OY

Company Profile: Faron Pharmaceuticals OY
Market Cap (USD): $127.9 M (July 1, 2024)
Country: Finland
Sector: Finnish Healthcare
Industry: Finnish Biotechnology

505. Sensorion SA

Company Profile: Sensorion SA
Market Cap (USD): $126.3 M
Country: France
Sector: French Healthcare
Industry: French Biotechnology

506. Diamyd Medical AB

Company Profile: Diamyd Medical AB
Market Cap (USD): $126.1 M (July 1, 2024)
Country: Sweden
Sector: Swedish Healthcare
Industry: Swedish Biotechnology

507. Paratek Pharmaceuticals, Inc.

Company Profile: Paratek Pharmaceuticals, Inc.
Market Cap (USD): $125.7 M (July 1, 2023)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

508. Infant Bacterial Therapeutics AB

Company Profile: Infant Bacterial Therapeutics AB
Market Cap (USD): $124.4 M (July 1, 2024)
Country: Sweden
Sector: Swedish Healthcare
Industry: Swedish Biotechnology

509. Nkarta, Inc.

Company Profile: Nkarta, Inc.
Market Cap (USD): $124.2 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

510. ReproCELL, Inc.

Company Profile: ReproCELL, Inc.
Market Cap (USD): $124.1 M
Country: Japan
Sector: Japanese Healthcare
Industry: Japanese Biotechnology

Stay in touch